HROB is a novel prognostic biomarker correlated with immune cell infiltration and tumor progression in lung adenocarcinoma
HROB is upregulated in LUAD and represents a promising prognostic biomarker, driving tumor proliferation, migration, and invasion.
Authors
- Yongjie Zhu (ORCID: https://orcid.org/0000-0002-8714-2647)
- Yumei Chen (ORCID: https://orcid.org/0000-0003-4756-4594)
- Zuotao Wu
- Yue Li (ORCID: https://orcid.org/0009-0008-0483-4789)
- Bo Chen
- Qiwei Li (ORCID: https://orcid.org/0000-0002-1020-3050)
- Y. J. Hu (ORCID: https://orcid.org/0000-0001-6845-1471)
- Chung-Hsien Wu
- Honglin Lu
Institutions
- The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine (CN)
- Guangxi University of Chinese Medicine (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- Yulin University (CN)
- Yulin Orthopedics Hospital of Chinese and Western Medicine (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1186/s12957-025-04070-z
- Citations
- 2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.04